Content validity of psoriatic arthritis screening questionnaires: systematic review
| العنوان: | Content validity of psoriatic arthritis screening questionnaires: systematic review |
|---|---|
| المؤلفون: | Venecia V. Landini Enríquez, María Luisa Peralta-Pedrero, Martha‐Alejandra Morales‐Sánchez, Fermín Jurado Santa-Cruz |
| المصدر: | International Journal of Dermatology. 59:902-914 |
| بيانات النشر: | Wiley, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | medicine.medical_specialty, Psa screening, Center of excellence, MEDLINE, Dermatology, Prom, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Surveys and Questionnaires, Psoriasis, medicine, Content validity, Humans, Mass Screening, In patient, Patient Reported Outcome Measures, business.industry, Arthritis, Psoriatic, medicine.disease, female genital diseases and pregnancy complications, 030220 oncology & carcinogenesis, Physical therapy, business |
| الوصف: | Background Psoriatic arthritis (PsA) is the main entity associated with psoriasis (PsO). Consequently, several PsA screening instruments have been developed, most of them are self-administered questionnaires, known as patient-reported outcome measures (PROMs). Objective To identify, summarize, and systematically evaluate the evidence of the content validity of PsA screening PROMs, in patients with PsO, by the dermatologist, based on COSMIN methodology. Methods A structured literature search was performed, until June 2019, that included development and/or validation studies of a questionnaire for the screening of PsA in patients with PsO. The evaluation was based on the PROMs' development, relevance, comprehensiveness, and comprehensibility. Results Eleven PROMs were included in the systematic review with four additional validation studies of the included instruments. Only ToPAS2 (Toronto Psoriatic Arthritis Screen) questionnaire had an adequate content validity. CONTEST (Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis), CEPPA (Center of Excellence for Psoriasis sand Psoriatic Arthritis), and SiPAS (Simple Psoriatic Arthritis Screening questionnaire) qualified as inadequate. Conclusions Despite the existence of eleven validated PsA screening PROMs, none were supported by very high-quality evidence of their content validity, which brings the opportunity for the creation of a new proposal PROM for the screening of PsA. |
| تدمد: | 1365-4632 0011-9059 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7814e9f4df0aea39fe7f37a4bb38a034Test https://doi.org/10.1111/ijd.14821Test |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....7814e9f4df0aea39fe7f37a4bb38a034 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 13654632 00119059 |
|---|